At Centered Primary Care, we are dedicated to helping our patients achieve their weight loss goals by offering the latest and most effective treatment options
Importantly, previous clinical data show that small-molecule drugs that target CB1 had fewer issues with gastrointestinal disorders 1 compared to, for example, one of todays leading GLP-1 agonist weight-loss drugs, semaglutide 2
During this phase, healthcare providers regularly monitor weight trends, medication tolerance, overall health, and any side effects of tirzepatide that may develop over time
To ensure youre getting the full benefit, storing the medication properly and following your healthcare providers instructions closely is important
The safety and efficacy of Semaglutide GLP-1 have been evaluated in clinical trials for up to two years, and ongoing studies continue to assess its long-term effects
Semaglutide mimics the action of the GLP-1 hormone, which increases insulin secretion, decreases glucagon secretion, slows down gastric emptying, and reduces appetite